With a weight-of-the-evidence approach, cancer risk assessment indentifies hazards, determines dose-response relationships, and assesses exposure to characterize the true risk. This book focuses on the quantitative methods for conducting chemical cancer risk assessments for solvents, metals, mixtures, and nanoparticles. It links these to the basic toxicology and biology of cancer, along with the impacts on regulatory guidelines and standards. By providing insightful perspective, Cancer Risk Assessment helps researchers develop a discriminate eye when it comes to interpreting data accurately and separating relevant information from erroneous.
Sobre el autor
CHING-HUNG HSU, Ph D, DABT, is a Vice President at Tai Gen
Biotechnology Co., Ltd. His professional experience includes
positions at Merck & Co., Inc., the U.S. Environmental
Protection Agency, and the California Environmental Protection
Agency. Dr. Hsu earned his BS from the National Taiwan University
and Ph D from the Massachusetts Institute of Technology. He
completed his postdoctoral training at the University of California
at Berkeley. Dr. Hsu is board-certified in toxicology by the
American Board of Toxicology. He has published numerous
professional papers, book chapters, and technical reports. Dr. Hsu
serves on the Editorial Board of two international peer-reviewed
journals.
TODD STEDEFORD, Ph D, JD, DABT, is a Toxicology Advisor
and In-house Counsel for a multinational specialty chemical
manufacturer. Previously, he was a human health toxicologist with
the U.S. Environmental Protection Agency and an adjunct scientist
with the Polish Academy of Sciences. Dr. Stedeford is
board-certified in toxicology by the American Board of Toxicology
and licensed to practice law in the District of Columbia and the
State of Louisiana. He has authored over eighty publications
including peer-reviewed scientific articles, government health
assessments, legal articles, and scientific and legal book
chapters.